A detailed history of 1858 Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, 1858 Wealth Management, LLC holds 4,523 shares of ABBV stock, worth $867,285. This represents 0.64% of its overall portfolio holdings.

Number of Shares
4,523
Previous 4,142 9.2%
Holding current value
$867,285
Previous $818 Million 1.74%
% of portfolio
0.64%
Previous 0.67%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

BUY
$164.99 - $203.87 $62,861 - $77,674
381 Added 9.2%
4,523 $804 Million
Q3 2024

Oct 21, 2024

SELL
$163.84 - $199.33 $24,412 - $29,700
-149 Reduced 3.47%
4,142 $818 Million
Q2 2024

Jul 18, 2024

SELL
$154.79 - $180.76 $15,943 - $18,618
-103 Reduced 2.34%
4,291 $736 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $604,614 - $680,938
4,394 New
4,394 $681 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $339B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track 1858 Wealth Management, LLC Portfolio

Follow 1858 Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1858 Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1858 Wealth Management, LLC with notifications on news.